Sudarshan Pharma reports strong Q2 and half-year financials

Sudarshan Pharma Industries Limited announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025. The company's unaudited consolidated total income from operations for the half-year stood at INR 1,27,747.00, with a profit before tax of INR 21,480.00 and a profit for the period of INR 15,710.00. For the quarter, consolidated total income from operations was INR 60,861.00, with profit before tax at INR 10,740.00 and profit for the period at INR 7,990.00.

On a standalone basis, the total income from operations for the half-year was INR 60,670.90, yielding a profit before tax of INR 21,684.40 and a profit for the period of INR 15,979.60. For the quarter ending September 30, 2025, standalone total income from operations reached INR 30,864.10, with a profit before tax of INR 10,879.80 and profit for the period at INR 8,172.90.

The financial results were published in Mumbai Lakshdeep and Financial Express, fulfilling regulatory disclosure requirements.